| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690653 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
In this population of locally advanced cervical-cancer patients, MR-guided HDR BT resulted in estimated 96% 2-year local control and excellent survival and toxicity rates.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sophia C. Kamran, Matthias M. Manuel, Linda P. Cho, Antonio L. Damato, Ehud J. Schmidt, Clare Tempany, Robert A. Cormack, Akila N. Viswanathan,